To the Editor—Early reports of persisting symptoms following COVID-19 signaled a
debilitating long-term fate for an undetermined proportion of people who survive COVID …

The value of large-scale, real-world data—from electronic health records (EHRs), for
example—has been used to establish vaccine efficacy, to elucidate the genetic etiologies of …

Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called 'long
COVID', are rising but little is known about prevalence, risk factors or whether it is possible to …

To the Editor—As the COVID Human Genetic Effort consortium (https://www. covidhge.
com/), we have studied genetic and immunological determinants of life-threatening COVID …

To the Editor—We report the kinetics of immune responses in relation to clinical and
virological features of a patient with mild-to-moderate coronavirus disease 2019 (COVID-19) …

To the Editor—To date, mainland China has promptly blocked hundreds of COVID-19
outbreaks that are associated with imported cases, enabling it to maintain the zero-COVID …

Peter Ashcroft, Sebastian Bonhoeffer and colleagues at ETH Zurich very helpfully alerted us
to a syntactical error in our original code, specifically that the likelihood as we had originally …

More than 4 years into the global COVID-19 pandemic, widespread infection with severe
acute respiratory syndrome coronavirus 2 (SARSCoV-2) has left millions of people around …

Long-term complications after coronavirus disease 2019 (COVID-19) are common in
hospitalized patients, but the spectrum of symptoms in milder cases needs further …

To the Editor—Public-health interventions aimed at curbing the spread of the coronavirus
SARS-CoV-2 have been limited to non-pharmaceutical interventions, including travel …